October 19, 2005

Bifeprunox (new drug) status update

A recent analyst presentation by Solvay pharmaceuticals suggests the their new schizophrenia drug (Bifeprunox) is moving forward.

In the report it stated:

"There was no new research announced on bifeprunox, an atypical antipsychotic drug, although Solvay noted that headline data from its full Phase III program (three placebo-controlled trials and two active reference controlled studies in around 2,600 patients) will be released before year-end. The Lehman analysts forecast a 40% probability of a launch in 2007 and worldwide peak turnover of $ 1.5 billion."

Source: PharmaMarketletter


I hope that this med launch in the market soon. Sometimes a pill can change all.
Regards from Spain.

Posted by: Elcarpi at October 23, 2005 11:30 AM

Please release this drug ASAP - no side effects, no weight gain!!!? It sound the best drug ever, don't delay it unnecessarily!!!

Posted by: jo at July 18, 2006 06:34 AM

Post a comment

Please enter this code to enable your comment -
Remember Me?
(you may use HTML tags for style)
* indicates required